Ingevity Corp current report, 31 January 2017

Business Context and Reporting Period

This Form 8-K is a current report filed by Ingevity Corporation on February 3, 2017, regarding events occurring on January 31, 2017. The filing addresses the departure of a senior executive and the associated compensatory arrangements.

Key Financial Metrics

This filing does not report general company financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The financial data provided is limited to specific severance and consulting payments related to the executive departure.

  • Severance Lump Sum: $400,000
  • 2016 Incentive Settlement: $587,000
  • 2016 Long-Term Cash Incentive: $40,404
  • Consulting Fees (Total): $100,000
  • Equity Acceleration: 1,461 Restricted Stock Units (RSUs) and 930 pro rata RSUs; potential vesting of 2,837 Performance Stock Units (PSUs).

Material Changes

The primary material change is the separation of Edward A. Rose, Executive Vice President and President of Performance Chemicals, effective January 31, 2017. This departure triggers specific severance obligations and a transition to a limited consulting role.

Outlook, Risks, and Unusual Items

Management Commentary and Arrangements:

  • Mr. Rose entered into a letter agreement formalizing his separation, including non-competition and non-solicitation provisions.
  • A consulting agreement was executed on February 1, 2017, for transitional matters ending April 30, 2017, at a rate of $33,333 per month.
  • Future PSU vesting is contingent on actual company performance as of December 31, 2018, as determined by the Compensation Committee.

Risks and Contingencies:

  • All payments are subject to income and employment tax withholding.
  • The filing notes that the summary is qualified by the full text of the attached agreements (Exhibits 10.1 and 10.2).

Investor Verification Checklist

  • Verify the total cash outflow impact of the severance package ($1,027,404 in immediate cash payments plus consulting fees).
  • Review the specific performance metrics required for the vesting of the 2,837 Performance Stock Units.
  • Confirm the scope of "limited and discrete transitional matters" defined in the consulting agreement to assess ongoing operational reliance.
  • Check for any subsequent filings regarding the appointment of a replacement for the Performance Chemicals division.